193 related articles for article (PubMed ID: 31665554)
21. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
[TBL] [Abstract][Full Text] [Related]
22. Up to 52 administrations of macrocyclic ionic MR contrast agent are not associated with intracranial gadolinium deposition: Multifactorial analysis in 385 patients.
Lee JY; Park JE; Kim HS; Kim SO; Oh JY; Shim WH; Jung SC; Choi CG; Kim SJ
PLoS One; 2017; 12(8):e0183916. PubMed ID: 28859167
[TBL] [Abstract][Full Text] [Related]
23. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
[TBL] [Abstract][Full Text] [Related]
24. No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after More than 20 Serial Injections of Macrocyclic Gadolinium-based Contrast Agents.
Radbruch A; Haase R; Kieslich PJ; Weberling LD; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Radiology; 2017 Mar; 282(3):699-707. PubMed ID: 27925871
[TBL] [Abstract][Full Text] [Related]
25. Signal changes in enhanced T1-weighted images related to gadolinium retention: A three-time-point imaging study.
Lersy F; Diepenbroek AL; Lamy J; Willaume T; Bierry G; Cotton F; Kremer S
J Neuroradiol; 2021 Mar; 48(2):82-87. PubMed ID: 32615207
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
27. Gadolinium deposition in the brain is related to various contrast agents: a matched case-control study.
Bi Q; Li H; Du J; Li H; Li Q; Wang J; Huang Y; Gong X
Clin Radiol; 2022 Apr; 77(4):299-306. PubMed ID: 35094817
[TBL] [Abstract][Full Text] [Related]
28. Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
Eisele P; Alonso A; Szabo K; Ebert A; Ong M; Schoenberg SO; Gass A
Medicine (Baltimore); 2016 Sep; 95(39):e4624. PubMed ID: 27684794
[TBL] [Abstract][Full Text] [Related]
29. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Gadolinium Retention After Serial Administrations of a Macrocyclic Gadolinium-Based Contrast Agent (Gadobutrol): A Single-Institution Experience With 189 Patients.
Yoo RE; Sohn CH; Kang KM; Yun TJ; Choi SH; Kim JH; Park SW
Invest Radiol; 2018 Jan; 53(1):20-25. PubMed ID: 28742734
[TBL] [Abstract][Full Text] [Related]
31. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
32. Impact of nasopharyngeal irradiation and gadolinium administration on changes in T
Tang R; Haacke EM; Zhang Y; Wang Q; He N; Chen KM; Yan F
J Magn Reson Imaging; 2020 Jan; 51(1):250-259. PubMed ID: 31124193
[TBL] [Abstract][Full Text] [Related]
33. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
[TBL] [Abstract][Full Text] [Related]
34. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
Ozturk K; Nascene D
Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
[TBL] [Abstract][Full Text] [Related]
35. Does MR arthrography cause intracranial gadolinium deposition?
Bunnell KM; Hemke R; Husseini JS; Torriani M; Huang SY; Bredella MA
Skeletal Radiol; 2020 Jul; 49(7):1051-1056. PubMed ID: 31982970
[TBL] [Abstract][Full Text] [Related]
36. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
[TBL] [Abstract][Full Text] [Related]
37. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.
Kanda T; Ishii K; Kawaguchi H; Kitajima K; Takenaka D
Radiology; 2014 Mar; 270(3):834-41. PubMed ID: 24475844
[TBL] [Abstract][Full Text] [Related]
38. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
39. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
